Adagio Medical’s 22% Surge Fuels Investor Confidence After First Patient Success with vCLAS Ultra Ablation System
ADGM’s 22% after‑hours rally follows the first‑patient test of its vCLAS Ultra‑Low‑Temperature Ablation system, promising safer, more durable cardiac arrhythmia treatment and boosting investor confidence.
2 minutes to read